OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Karen Canfell: The Need for Collaboration and Coordination in Space Flight and in Global Oncology

Enhertu Plus Pertuzumab Approved in the EU for First-Line HER2-Positive Metastatic Breast Cancer: A New Benchmark After More Than a Decade

Pashtoon Kasi: 'Inside-Out' Pattern of Response from NEST Trial in Colon Cancer

Deborah McNamara Appointed National Director of Ireland’s National Cancer Control Programme

Oncology News, Insights, Stories by OncoDaily

Jasmine Kamboj
Voices

Jasmine Kamboj: The Reach of COGC 2026 Was Above and Beyond What We Hoped

Otumfuo Osei Tutu II
Voices

His Royal Majesty Otumfuo Osei Tutu II, Asantehene, at “An Evening for Cure” Fundraising Gala Supporting $100 Million Cancer Center in Ghana

SANOVO
Lung Oncology

SANOVO: Osimertinib Plus Savolitinib Moves MET-Directed Therapy Into First-Line EGFR-Mutated NSCLC

Iza-Bren Reaches the Phase III PFS Endpoint in HR+/HER2− Advanced Breast Cancer: Why PANKU-Breast01 Matters

Florian Lordick: The Evolving Role of Adjuvant Treatment in GIST

Radwa A. Yassin: Exciting and Historic Opportunity at The 1st ASCO Africa Regional Council

Christopher Jackson and the Question Oncology Cannot Avoid: Who Is Progress Really For?

Registration Open: ODC Life Sciences Invites Clinical Development Leaders to ‘Brazil Unlocked’ in Cambridge, Massachusetts

Manish Shah: Phase 2 NEST Trial Shows Promising Neoadjuvant BOT/BAL Results in Colon Cancer

FDA Approves Daraxonrasib: Here is What Oncologists Have to Say

Voices
Huzaifah Salat

Huzaifah Salat: Pray Like It All Depends on God, and Work Like It All Depends on You

IARC Opens Applications for Senior Visiting Scientist Position

Advancing Pediatric Cancer Care Through Personal Experiences - Servier Pharmaceuticals

Gilberto Lopes: Turning Evidence Into Action to Implement Lung Cancer Policy at WCLC26

Shabnam Gujadhur: Lived Experience as Authority - Redefining Women’s Mental Health in Survivorship

Hadi Mohamad Abu Rasheed: Patient Navigation Should be Designed Into the Cancer-Care Pathway

Astha Thakkar: Grateful for the Opportunity to Present at the Global Oncology Congress 2026

FDA Approvals
Ziihera

FDA Approves Ziihera With and Without Tislelizumab Plus Chemotherapy for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

Celebrities and Cancer

OncoCalendar

2026 Advances in Chronic Graft-Versus-Host Disease

Memorial Sloan Kettering Cancer Center (MSK)

30 Oct
Graft-Versus-Host Disease

The ICISi Masterclass in Imaging of Prostate Cancer

International Cancer Imaging Society (ICIS)

23 Oct
ICISi Masterclass

The 37th Annual Fall Foliage Cancer Conference

Continuing Cancer Education, Inc

23 Oct
Fall Foliage Cancer

The APPOS Chicago 2026

Advanced Practice Providers Oncology Summit (APPOS)

06 Nov
APPOS Chicago 2026

GUPS Virtual Education Series: Bridges in Genitourinary Oncology

Genitourinary Pathology Society

01 Oct
Genitourinary Oncology

Immune-oncology
Talquetamab IMWG Immunotherapy Registry

Talquetamab in R/R Multiple Myeloma: Real-World Analysis From the IMWG Immunotherapy Registry

What Happens If CAR T-Cell Therapy Fails? Relapse, Refractory Disease, and Next Treatment Options

Anti-CD7 CAR T-Cell Therapy Shows Promising CNS Activity in Relapsed or Refractory T-ALL/LBL

ctDNA and MRD in NSCLC: Emerging Clinical Applications in the Immunotherapy Era

CAR T-Cell Therapy Death Rate: Treatment-Related Mortality, Causes of Death, and Risk Factors

CD20 × CD3 Bispecific Antibodies in B-Cell Lymphoma: Real-World Safety, Efficacy, and Healthcare Use in Spain

5 Must-Read Posts About CAR-T This Week

Gastrointestinal-Oncology
Esophageal Squamous Cell Carcinoma Biomarkers: PD-L1, Molecular Features and Emerging Targets

Esophageal Squamous Cell Carcinoma Biomarkers: PD-L1, Molecular Features and Emerging Targets

Ziihera Plus Chemotherapy Improves Overall Survival in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

Phase 2 NEST Trial: Neoadjuvant BOT/BAL in Localized Colon Cancer

FDA Approves Daraxonrasib: First-in-Class RAS Inhibitor for Metastatic Pancreatic Cancer

SKYSCRAPER-07: Atezolizumab ± Tiragolumab After dCRT in Unresectable ESCC

TALENTOP: Liver Resection After Atezolizumab and Bevacizumab in Locally Advanced HCC

10 Must-Read Posts In GI Oncology This Week

Breast-Oncology
Enhertu

Enhertu Plus Pertuzumab Approved in the EU for First-Line HER2-Positive Metastatic Breast Cancer: A New Benchmark After More Than a Decade

Trastuzumab deruxtecan Plus Pertuzumab Approved in EU for First-Line HER2-Positive Metastatic Breast Cancer

Iza-Bren Reaches the Phase III PFS Endpoint in HR+/HER2− Advanced Breast Cancer: Why PANKU-Breast01 Matters

ctDNA During Neoadjuvant Therapy: Toward Real-Time Risk Stratification in Early Breast Cancer

5 Alarming Real-World Findings in HR-Positive, HER2-Low Metastatic Breast Cancer

ELEVATE: Can Elacestrant Become a New Endocrine Backbone After CDK4/6 Inhibition?

ASCO 2026 Guideline: A Risk-Adapted Framework for Early HR-Positive, HER2-Negative Breast Cancer

Lung-Oncology
SANOVO

SANOVO: Osimertinib Plus Savolitinib Moves MET-Directed Therapy Into First-Line EGFR-Mutated NSCLC

XPO1 Inhibition May Reprogram Immune Resistance in SCLC: The TRIM21–IRF3–TNFSF15–TREM2 Axis

AstraZeneca Completes Zegfrovy Deal for EGFR Exon 20 Insertion NSCLC

Adjuvant Crizotinib Fails in Resected ALK-Positive NSCLC: What E4512 Tells Us About Targeted Therapy in Early Disease

7 Powerful Advances in the ASCO 2026 Guideline for Driver-Positive Stage IV NSCLC

When EGFR-Mutant NSCLC Becomes SCLC: Can Immunotherapy Become Relevant Again?

Are We Irradiating the Immune System? Thymic Dose Emerges as a Potential Risk Factor in NSCLC

OncoDaily TV
Treatment Paradigms, Karine Tawagi

Evolving Treatment Paradigms in Muscle-Invasive Bladder Cancer

Cancer in Women

Cancer in Women As a Global Health and Economic Issue: Dr. Maira Caleffi

oncoffee, palliative

ONCOFFEE: Colorectal Cancer, Palliative Care, and the Human Side of Oncology: Santiago Fontes

Empowering Oncologists

Empowering Oncologists: How Policy impacts Medicine?

WHO

Mission is possible: WHO said 2030 – Rwanda said 2027: Dr. Sabin Nsanzimana

Current Landscape

The Current Landscape and Future of CAR-T in Aggressive B-Cell Lymphoma

Experts by Experience

Experts by Experience with Carmen Monge

Fighting Cervical Cancer

From Engineering to Fighting Cervical Cancer

Dr. Beatrice Addai Wiafe

Fighting Cancer With Peace And Love: Dr. Beatrice Addai Wiafe

Maggie Smith breast cancer

Dame Maggie Smith and Courageus Breast Cancer Journey: Filming Harry Potter During Chemotherapy

Petra Jankowska

Leading with Humanity in Modern Oncology: Dr. Petra Jankowska

Princess Dina

Episode 18: Global Health Dialogues with Princess Dina and Dr Urvi Shah

Not To Miss
pertuzumab

Trastuzumab deruxtecan Plus Pertuzumab Approved in EU for First-Line HER2-Positive Metastatic Breast Cancer

AstraZeneca Completes Zegfrovy Deal for EGFR Exon 20 Insertion NSCLC

BeOne Medicines Reaches U.S. Government Agreement to Expand Access to Cancer Medicines

FDA Approves PharmaEssentia’s BESREMi for Adults With Essential Thrombocythemia

Karyopharm Submits FDA Application for Selinexor Plus Ruxolitinib in Myelofibrosis

Highlights From Community Oncology Global Congress 2026, Day 3

Highlights From Community Oncology Global Congress 2026, Day 2

OncoGrants
McCaskill-Stevens Career Development

NCI Worta McCaskill-Stevens Career Development Award 2027

Human Cancers

NCI Specialized Programs of Research Excellence in Human Cancers 2026

NCI

NCI Assay Validation of Cancer Biomarkers UH3 Grant 2026

Academic Clinical Trials

Blood Cancer United Academic Clinical Trials Program 2026–27

Validation of Biomarker

KWF Dutch Cancer Society Call for Validation of Biomarker Candidates 2027

Pediatric Cancer

Florida DOH Live Like Bella Pediatric Cancer Research Grants 2026–27

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Gabriele Todisco

Gabriele Todisco

Oncologists Location Milan, Italy
Dilyara Kaidarova

Dilyara Kaidarova

Oncologists Location Almaty, Kazakhstan
Yelena Janjigian

Yelena Janjigian

Oncologists Location New York, USA
Donjeta Bali Alia

Donjeta Bali Alia

Oncologists Location Tirana, Albania
Nagashree Seetharamu

Nagashree Seetharamu

Oncologists Location Long Island, USA
Filipe Coutinho

Filipe Coutinho

Oncologists Location Santo Tirso, Portugal
Saima Alvi

Saima Alvi

Oncologists Location
Ruzanna Papyan

Ruzanna Papyan

Oncologists Location Yerevan, Armenia

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
MASCC

Physical Activity in Cancer Care: Insights from the Latest Supportive Care Digest - MASCC

Allan Pereira

Allan Pereira: TALENTACE Strengthens TACE with Atezolizumab and Bevacizumab in HCC

Joshua Okyere

Joshua Okyere: Economic Dependence Is a Barrier to Cancer Screening

Avirup Guha

Avirup Guha: Strongest Randomized Evidence Yet for Organizing Cardio Oncology Around Prostate Cancer

Jeff Allen

Jeff Allen: New Evidence Supporting ctDNA as an Early Indicator of Treatment Benefit

William Dale

William Dale: Geriatric Assessment and Management Linked to Better Coping and Clinical Outcomes

OncoDaily Medical Journal

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts

Radiation Oncology

10.69690/ODMJ-018-0826-7920

Short-Course Palliative Radiotherapy for Tumour-Related Bleeding in End-of-Life Care: A Focused Literature Review
Abstracts

Pediatric Oncology

10.69690/ODMJ-018-0826-7952

FLASH radiotherapy: A Potential Way to Protect the Developing Brain in Pediatric Oncology
Abstracts

GI Oncology

10.69690/ODMJ-018-0826-7947

Real World Clinical Insights in Combination of Trifluridine-Tipiracil with Bevacizumab for Metastatic Colorectal Cancer
Abstracts

Hematology

10.69690/ODMJ-018-0826-7945

Plasma cell survival: The impact of extracellular ATP
Abstracts

Breast Cancer

10.69690/ODMJ-018-0826-7965

A Systematic Comparison of ICG Fluorescence vs Dual-Tracer Sentinel Lymph Node Biopsy in Breast Cancer Staging
Abstracts